Outcomes of Endolymphatic Shunt Surgery for Meniere's Disease: Comparison With Intratympanic Gentamicin on Vertigo Control and Hearing Loss

被引:15
|
作者
Derebery, M. Jennifer [1 ,2 ]
Fisher, Laurel M. [1 ]
Berliner, Karen [1 ]
Chung, Janice [3 ]
Green, Katherine [3 ]
机构
[1] House Ear Res Inst, Los Angeles, CA 90057 USA
[2] House Ear Clin, Los Angeles, CA USA
[3] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA
关键词
Endolymphatic shunt surgery; Gentamicin; Meniere's disease; MASTOID SHUNT; SAC SURGERY; SURGICAL-MANAGEMENT; SUBARACHNOID SHUNT; THERAPY; MUTATION; DECOMPRESSION; METAANALYSIS; PATIENT; ERA;
D O I
10.1097/MAO.0b013e3181dd13ac
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To compare proportions of the combined outcome of vertigo control and hearing preservation between intratympanic gentamicin injections and endolymphatic sac shunt surgery for intractable vertigo in Meniere's disease patients. Study Design: Analysis of published data and retrospective review. Setting: Tertiary otologic referral center. Patients: Patients with Meniere's disease who had failed medical management: 183 surgical patients (shunt group) and 203 patients obtained from 6 published gentamicin treatment studies (gentamicin group). Cases were included if hearing and vertigo data were available before and after treatment with no previous surgical or injection treatment. Average patient age ranged from 45 to 59 years across studies. Gentamicin studies had nearly equal female to male subjects, whereas the shunt group was 60% female. Interventions: Endolymphatic sac shunt surgery or intratympanic gentamicin treatment of differing doses and injection schedules. Main Outcome Measure: Proportion of patients with best combined vertigo control/hearing preservation. Hearing preservation is 10 dB or less increase in pure-tone average. Outcomes were categorized as follows: complete vertigo control/hearing preservation (best), complete vertigo control/hearing loss, incomplete vertigo control/hearing preservation, and incomplete vertigo control/hearing loss (worst). Results: The shunt group showed a significantly higher percentage of the best outcome (62%) than the gentamicin group (56%, p <= 0.003), as well as a higher rate of complete vertigo control (86% versus 71%; p <= 0.001). Conclusion: A higher percentage of patients undergoing shunt surgery attained complete vertigo control/hearing preservation relative to intratympanic gentamicin. There continues to be significant variability in gentamicin outcomes, suggesting that the technique requires additional refinement before consistently producing good outcomes.
引用
收藏
页码:649 / 655
页数:7
相关论文
共 50 条
  • [1] A comparison of endolymphatic shunt surgery and intratympanic gentamicin for meniere's disease
    Gibson, Alec W.
    Moon, Il Joon
    Golub, Justin S.
    Rubinstein, Jay T.
    [J]. LARYNGOSCOPE, 2020, 130 (10): : 2455 - 2460
  • [2] Intratympanic dexamethasone, intratympanic gentamicin, and endolymphatic sac surgery for intractable vertigo in Meniere's disease
    Sennaroglu, L
    Sennaroglu, G
    Gursel, B
    Dini, FM
    [J]. OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2001, 125 (05) : 537 - 543
  • [3] Factors relating to the vertigo control and hearing changes following intratympanic gentamicin for intractable Meniere's disease
    Horii, Arata
    Saika, Takanori
    Uno, Atsuhiko
    Nishiike, Suetaka
    Mitani, Kenji
    Nishimura, Masato
    Kitahara, Tadashi
    Fukushima, Munehisa
    Nakagawa, Aya
    Masumura, Chisako
    Sasaki, Tomo
    Kizawa, Kaoru
    Kubo, Takeshi
    [J]. OTOLOGY & NEUROTOLOGY, 2006, 27 (06) : 896 - 900
  • [4] Vestibular Function and Vertigo Control after Intratympanic Gentamicin for Meniere's Disease
    Nguyen, Kimanh D.
    Minor, Lloyd B.
    Della Santina, Charles C.
    Carey, John P.
    [J]. AUDIOLOGY AND NEURO-OTOLOGY, 2009, 14 (06) : 361 - 372
  • [5] Hearing loss after intratympanic gentamicin therapy for unilateral Meniere's Disease
    Martin, E
    Perez, N
    [J]. OTOLOGY & NEUROTOLOGY, 2003, 24 (05) : 800 - 806
  • [6] Effect of intratympanic gentamicin on hearing and tinnitus in Meniere's disease
    Eklund, S
    Pyykkö, I
    Aalto, H
    Ishizaki, H
    Vasama, JP
    [J]. AMERICAN JOURNAL OF OTOLOGY, 1999, 20 (03): : 350 - 356
  • [7] Hearing loss following intratympanic instillation of gentamicin for the treatment of unilateral Meniere's disease
    Kaplan, DM
    Nedzelski, JM
    Al-Abidi, A
    Chen, JM
    Shipp, DB
    [J]. JOURNAL OF OTOLARYNGOLOGY, 2002, 31 (02): : 106 - 111
  • [8] Hearing loss after intratympanic gentamicin in Meniere's disease. Retrospective study
    Villaoslada-Fuentes, Cristina
    Jose Fernandez-Nava, Maria
    Ferreira-Cendon, Sofia
    Villaoslada-Fuentes, Rosana
    Sanchez-Gomez, Hortensia
    Batuecas-Caletrio, Angel
    [J]. REVISTA ORL, 2021, 12 (03) : 243 - 252
  • [9] Control of vertigo in Meniere's disease by intratympanic dexamethasone
    Weckel, A.
    Marx, M.
    Esteve-Fraysse, M. -J.
    [J]. EUROPEAN ANNALS OF OTORHINOLARYNGOLOGY-HEAD AND NECK DISEASES, 2018, 135 (01) : 7 - 10
  • [10] Intratympanic gentamicin for control of vertigo in Meniere's disease: Vestibular signs that specify completion of therapy
    Minor, LB
    [J]. AMERICAN JOURNAL OF OTOLOGY, 1999, 20 (02): : 209 - 219